National Resource for Translational and Developmental Proteomics
Northwestern Proteomics is home to the National Resource for Translational and Developmental Proteomics (NRTDP) made possible under a $7 million
renewable grant in 2015 from the National Institute of General Medical Sciences, National Institutes of Health and supported by the Sherman Fairchild Foundation.
The mission of the Resource is to develop new proteomics technologies; apply them to timely questions in basic, translational, and clinical research, and communicate our research findings to the scientific community at large.
The Resource is dedicated to accelerating a significant shift in how protein molecules are analyzed by mass spectrometry, with a focus on intact protein measurements propelling a variety of national interests in technology development, systems biology, and clinical/translational proteomics. Many of our driving biomedical projects originate from clinical and basic research programs that utilize both targeted and untargeted analyses. Beyond the development of new technology, this Biomedical Technology Research Resource (BTRR) is committed to effective training and dissemination of proteomics methods to diverse laboratories and scientists. Much of this is achieved through the Scholar Exchange Program, standardized protocols and interactions through Satellite Centers.
NRDTP works with scientists from across the US to build new technologies that support the development of new approaches to diagnosing and treating disease.
Our project list continues to grow as our collaborations and outreach deepen.